Literature DB >> 7252687

Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis.

J J Corrigan, L M Taussig, R Beckerman, J S Wagener.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252687     DOI: 10.1016/s0022-3476(81)80468-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

Review 1.  Vitamin K in cystic fibrosis.

Authors:  S P Conway
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

2.  Increased PIVKA-II concentrations in patients with cystic fibrosis.

Authors:  M de Montalembert; G Lenoir; A Saint-Raymond; J Rey; J J Lefrère
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

3.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

4.  Plasma vitamin K1 concentrations in cystic fibrosis.

Authors:  I A Choonara; M J Winn; B K Park; J M Littlewood
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

5.  Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation.

Authors:  L Lancellotti; C D'Orazio; G Mastella; G Mazzi; U Lippi
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 6.  Current clinical management of hepatic problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

7.  Cystic fibrosis: benefits and clinical outcome.

Authors:  K O McKay
Journal:  J Inherit Metab Dis       Date:  2007-07-06       Impact factor: 4.982

8.  Coagulopathy as initial manifestation of concomitant celiac disease and cystic fibrosis: a case report.

Authors:  Aco Kostovski; Nikolina Zdraveska
Journal:  J Med Case Rep       Date:  2011-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.